Smart Bioelectrical Interfaces to Assess Cancer in vitro
Janire Saez a b c
a Microfluidics Cluster UPV/EHU, BIOMICs Microfluidics Group, Lascaray Research Center, University of the Basque Country UPV/EHU, Avenida Miguel de Unamuno, 3, Vitoria-Gasteiz, Spain
b Basque Foundation for Science, IKERBASQUE, E-48011 Bilbao, Spain
c Bioaraba Health Research Institute, Microfluidics Cluster UPV/EHU, Vitoria-Gasteiz, Spain
Materials for Sustainable Development Conference (MATSUS)
Proceedings of MATSUS Fall 2023 Conference (MATSUSFall23)
#BIOEL - Bioelectronics
Torremolinos, Spain, 2023 October 16th - 20th
Organizers: Francesca Santoro and Achilleas Savva
Invited Speaker, Janire Saez, presentation 187
DOI: https://doi.org/10.29363/nanoge.matsus.2023.187
Publication date: 18th July 2023

The generation of in vitro platforms capable of mimicking the in vivo situation as an alternative to animal models and/or monitoring cellular processes is necessary for medicine and drug discovery [1]. In this sense, Smart Bioelectronics arise from the combination of smart functional materials, bioelectronics and microfluidics, making Smart Bioelectronics a powerful tool to control cellular microenvironments.

Smart functional materials such as poly(N-isopropylacrylamide) (pNIPAAm) can undergo structural changes due to their inherent lower critical solution temperature (LCST) phase transition in water at 32 ºC. On its side, poly(3,4-ethylenedioxythiopene):poly(styrene sulfonate) (PEDOT:PSS) is a widely used conducting polymer in the bioelectronics field, due to its mixed ionic and electronic conduction properties. When mixing both polymers, the developed PEDOT:PSS/pNIPAAm co-polymer modulates cellular adhesion/detachment of cancer cells and the electrochemical monitoring of the process [2-3].

Moreover, PEDOT can be tailored biochemically and mechanically to replicate a specific tissue. PEDOT polymers made in combination with biopolymers and glycosaminoglycans such as collagen and hyaluronic acid can be used in the generation of 3D bioelectronic interfaces with physiologically relevant conditions [4-5]. On the other hand, microfluidic devices offer optical transparency, miniaturization, and controlled media perfusion required in organ-on-a-chip models. The interface between 3D bioelectronics and microfluidic devices enables the real-time electrical and optical monitoring of cellular processes in a controlled microenvironment.

Here, we present an overview of different 2D and 3D Smart Bioelectronic interfaces for the simultaneous electrical and optical monitoring of cancer cell migration.

J.S. acknowledges funding from the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant, ICE-METs (No. 842356). JS also acknowledges the Ikerbasque, Basque Foundation for Science, Departamento de Salud del Gobierno Vasco, FUNDACION Vital Fundazioa, Gobierno de España, Ministerio de Ciencia y Educación de España” under grant PID2020-120313 GB-I00/AIE/10.13039/501100011033, and Gobierno Vasco Dpto. Educación for the consolidation of the research groups (IT1633-22).

© FUNDACIO DE LA COMUNITAT VALENCIANA SCITO
We use our own and third party cookies for analysing and measuring usage of our website to improve our services. If you continue browsing, we consider accepting its use. You can check our Cookies Policy in which you will also find how to configure your web browser for the use of cookies. More info